Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Jinju
Clinical trial register · South Korea

Clinical Trials in Jinju, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3409 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
3409
Studies in scope
all four open statuses
1874
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Seoul 2866 Daegu 553 Seongnam-si 485 Busan 470 Goyang-si 399
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul2866 Daegu553 Seongnam-si485 Busan470 Goyang-si399 Incheon348 Suwon337 Daejeon214 Gyeonggi-do211 Gwangju208 Seongnam206 Cheongju-si188 Yangsan123 Bucheon-si111 Wŏnju92 Jeonju92 Hwasun85 Ulsan81 Ansan-si61 Jinju55 Anyang-si52 Goyang52 Chuncheon48 Pusan42 Hwasun-gun41 Ansan39 Guri-si39 Changwon38 Junggu37 Yongin-si36 Cheonan35 Namdong-gu33 Jeollanam-do33 Uijeongbu-si29 Gwangmyeong27 Cheonan-si27 Gangneung25 Anyang25 Seogu24 Deagu23 Seongnam-si, Gyeonggi-do21 Jeju City20 Hwaseong-si19 Gangnam-gu15 GangnamGu14 SeodaemunGu14 Ilsan14 Soeul14 Dongjak-gu13 Yongin13 Seongnam-si Gyeonggi-do13 SongpaGu12 Songpa-gu12 Iksan12 Gangwon-do12 Jongno-gu12 SeochoGu11 Changwon-si11 Sejong11 Goyang-si Gyeonggi-do11 Songpagu11 Haeundae-gu10 Bundang Gu10 Donggu10 Suwon Kyunggi-do10 Chungju9 Seongbuk-Gu8 Gyeongsan-si8 Seodaemun-gu8 Gyeongsangnam-do7 Chungcheongbuk-do7 Seocho7 Multiple Locations7 Cheongju Chungbuk6 Dalseo-gu6 Gyeongsang6 Jeollanam6 Hwasun Gun6 Suwon Gyeonggi-do5 Seocho-Gu5 Songpa-dong5 Jongno -Gu5 Jeonnam5 Gangnam-Gu5 Cheonju5 Bupyeong-gu5 Dongnam-gu, Cheonan-si4 Namdong4 Wonju-si, Gangwon-do4 IlsandongGu GoyangSi4 Cheongju Chungcheongbuk-do4 Goyang-si, Gyeonggi-do4 Seodaemun-Gu4 Haeundae4 Suncheon4 Hwasun-Gun4 Dongjak3 Gangnam3 Buk-gu3 Yeongdeungpo-gu3 Many Locations3 Jungbuk3 Yŏngin3 Sinchon-dong3 Dongjak Gu3 BundangGu SeongnamSi3 Guro-gu3 Seocho-gu3 Inchon3 Seongdong-gu3 Songpa-Gu3 Kwangju3 Jongno-Gu3 Dongdaemun-gu3 BukGu3 Ganggu3 Bupyeong-Gu3 Gangseo-gu3 Taegu3 Seongam2 Yangsan-si, Gyeongsangnam-do2 Buk-Gu2 Bundang-Gu, Seongnam-Si2 Bukgu2 Hwasungun2 Jeju-do2 Dong-gu Ulsan2 Daejoen2 Gangneung-si2 Iksan-si2 Seongnam Gyeonggi2 Yangcheon2 Bucheon Kyunggi-Do2 Yongsan-Ku Seoul2 Changwon-Si2 Namdong-Gu2 Kangwon-do2 Ansan-si, Gyeonggi-do2 Nam-Gu2 Chilgok2 PaldalGu SuwonSi2 HwasunGun2 Andong2 Seoungnam-si2 Chungcheongnam-do2 Seongdong2 Hwasun-gun, Jeollanam-do2 Bucheon-si, Gyeonggi-do2 Yongsan-gu2 Dong-gu2 Bucheonsi Weonmigu2 Buk Gu2 Hwaseong2 Gimpo-si2 Siheung2 Ilsandong-gu2 Seodaemun2 Jeollabuk-do2 Jeongnam2 NamdongGu2 Sungnam1 Yangsang1 Beon-gil Bundang-gu1 Gwangjin-Gu1 Ilsandong-gu, Goyang-si1 Hanam1 서구1 Dongan1 Hwasun-eup1 Chungcheongbuk Do1 Gyeongju1 Sinchŏn-dong1 Hwasan1 Gangnam Gu1 Anam1 Buchon1 Kyungki-do1 Kangwondo1 Gyeongnam1 Jungnam1 Gwangjingu1 HaeundaeGu1 Cheonansi1 Dalseogu1 DanwonGu AnsanSi1 Irwon-dong1 Yongsan1 Gyeongin1 Sangam-dong1 Yangpyeong1 Gumi1 Pyeongchon1 Jeju Special1 Jungni I Gu1 Dong-gu, Ulsan1 Anyang-si, Gyeonggi-do1 Bucheon, Gyeonggi-do1 Cheonan-Si1 Jinju-si Gyeongsangnam-do1 Hwaseong-si, Gyeonggi-do1 Busan-si1 Naju1 Ilsan-gu1 Dongan-Gu, Anyang-Si1 Gwangju Gwangyeoksi1 Pohang1 BusanjinGu1 Tongdaemun-Gu1 Icheon1 Gandong-gu1 Seowon-Gu1 Gyeongsangbuk-do1 Taejŏn1 Bundang-gu1 Ansan-si Gyenggi-do1 Namwon1 Suwon-si Gyeonggi-do1 Suwon-si, Gyeonggi-do1 Geumam1 Daehak-ro, Jongno-gu1 Ilsandong1 Cheonan Si1 Jeonlabuk-do1 Songpa1 Namyangju1 Yangju1 Hwasun-Eup1 Seongnamsi Bundang1 Korea1 Jongno-gu, Seoul1 Seocho-gu, Seoul1 Bundang-gu, Seongnam-si1 Ilsandong-Gu, Goyang-Si1 Eunpyeong-gu1 Bucheon-si Kyunggi-do 145841 Heungdeok-Gu1 Inceon1 SeongbukGu1 Hwasun-eup, Hwasun-gun1 Gangdong-gu1 Gwangjin-gu1 JinJoo1 Pyeongtaek-si1 Sejong-si1 Pusan Kwangyokshi1 Dalseo1 Seocho -Gu1 Kangwon Do1 Iksan Si1 Gunpo1 Hwasŏng1 Jeonam1 Kyonggi-do1 Jemulpo-gu1 Jongno1 Cheongiu1 Dongjakgu1 Suweonsi Paldalgu1
All 258 locations
Target enrolment
to

Trials with a site in Jinju

55 of 3409 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
NCT07684742Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina
Gyeongsang National University Hospital
Phase 4
2,200
Jinju
2026-07-01
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Daegu, Seongnam-si, Suwon, Cheongju-si, Goyang-si, Pusan, Yangsan, Jinju
2025-12-22
Recruiting
Daiichi Sankyo
Phase 3
686
Cheongju-si, Goyang-si, Jinju, Seongnam, Seoul, Suwon
2025-10-24
Recruiting
Eli Lilly and Company
Phase 3
4,500
Ansan-si, Bucheon-si, Busan, Daegu, Dongjak-gu, Guri-si, Incheon, Jinju
2025-10-15
Recruiting
Samsung Medical Center
Not applicable
3,500
Bucheon-si, Daegu, Gwangju, Gwangmyeong, Ilsan, Incheon, Jeonju, Jinju
2025-10-02
Recruiting
BeOne Medicines
Phase 3
500
Seogu, Seongnam-si, Jinju, SeochoGu, SeodaemunGu, Seoul
2025-09-04
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164Myocardial Infarction (MI), Heart Failure
Chonnam National University Hospital
Not applicable
780
Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam
2025-07-15
Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07405931Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer
Ulsan University Hospital
Not applicable
414
Busan, Goyang, Incheon, Jinju, Ulsan
2025-07-09
Recruiting
Novartis Pharmaceuticals
Observational
70
Jinju, Busan, Gwangju
2025-04-02
Recruiting
BioNTech SE
Phase 3
621
Seoul, Goyang-si, Suwon, Jinju, Incheon, Cheongju-si
2025-02-03
Recruiting
BioNTech SE
Phase 2/3
1,580
Cheongju-si, Daejeon, Goyang-si, Incheon, Jinju, Seongnam-si, Seoul, Suwon
2025-01-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Wŏnju, Gwangju, Ansan-si, Jinju, Pusan, Deagu, Seoul
2024-12-02
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Cheongju-si, Jinju, Seoul
2024-11-22
Active, closed
BioNTech SE
Phase 2
110
Cheongju-si, Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2024-08-05
Recruiting
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
NCT06227754ST Elevation Myocardial Infarction, Myocardial Infarction
Chonnam National University Hospital
Not applicable
1,500
Daegu, Gwangju, Iksan, Incheon, Jeju City, Jeonju, Jinju, Seoul
2024-03-25
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Incheon, Jinju, Seongnam-si, Gyeonggi-do, Seoul
2024-02-20
Active, closed
Samsung Bioepis Co., Ltd.
Phase 1
163
Ansan, Busan, Daegu, Hwasun, Incheon, Jinju, Seongnam, Seoul
2024-01-16
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Seongnam-si, Jinju, Hwasun, Busan, Daegu, Incheon, Seoul
2023-12-20
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
Phase 3
285
Seongnam-si, Suwon, Jinju, Incheon, Seoul
2023-12-18
Recruiting
AbbVie
Phase 1
325
Busan, Jinju, Cheongju-si, Seoul
2023-11-09
Active, closed
AstraZeneca
Phase 3
895
Cheongju-si, Incheon, Jinju, Seoul, Suwon
2023-10-24
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc.
Phase 2
220
Goyang-si, Suwon, Jinju, Incheon, Hwasun-gun, Seoul, Soeul
2023-07-31
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
Taiho Oncology, Inc.
Phase 2
120
Busan, Daegu, Jinju, Seongnam, Seoul
2023-07-05
Active, closed
Amgen
Phase 3
509
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Incheon, Jinju, Seongnam-si, Gyeonggi-do, Seoul, Ulsan
2023-05-31
Recruiting
Seoul National University Bundang Hospital
Observational
1,240
Daegu, Gyeonggi-do, Hwasun, Ilsan, Jinju, Seongnam-si, Seoul, Yangsan
2023-04-01
Recruiting
Abion Inc
Phase 2
178
Goyang-si, Suwon, Dongjak, Seoul, Sinchon-dong, Cheongju-si, Incheon, Jinju
2023-01-17
Recruiting
Yuhan Corporation
Phase 1/2
147
Seongnam-si, Suwon, Jinju, Cheongju-si, Incheon, Seoul, Ulsan
2022-08-26
Active, closed
AstraZeneca
Phase 3
341
Goyang-si, Gyeonggi-do, Jinju, Seoul, Suwon
2022-08-03
Active, closed
Drug-Coated Balloon in Patients With High Bleeding Risk
NCT05221931Coronary Artery Disease
Samsung Medical Center
Not applicable
1,359
Ansan, Cheongju-si, Daegu, Gangneung, Gwangju, Gwangmyeong, Incheon, Jinju
2022-07-29
Active, closed
Novartis Pharmaceuticals
Observational
670
Daegu, Kangwon Do, Wŏnju, Goyang-si, Guri-si, Jinju, Jeonju, Iksan Si
2022-05-09
Active, closed
Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)
NCT05369182Coronary Microvascular Disease, Coronary Artery Disease, Ischemic Heart Disease
Samsung Medical Center
Observational
1,003
Gwangju, Jinju, Seongnam, Seoul
2022-04-22
Active, closed
BeOne Medicines
Phase 3
799
BusanjinGu, Seogu, Seongnam-si, BukGu, Jinju, HwasunGun, GangnamGu, SeochoGu
2022-03-10
Active, closed
Daiichi Sankyo
Phase 3
740
Seongnam-si, Jinju, Cheongju-si, Daegu, Goyang-si, Seoul, Songpa-gu
2022-03-04
Active, closed
AstraZeneca
Phase 3
390
Daegu, Jinju, Seoul, Suwon
2022-02-21
Active, closed
AstraZeneca
Phase 3
791
Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2022-02-18
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Daegu, Wŏnju, Bundang Gu, Jinju, Yangsan, Seoul, Cheongju-si, Busan
2021-11-23
Active, closed
AbbVie
Phase 1
520
Busan, Seongnam, Jinju, Cheongju-si, Seoul
2021-10-13
Active, closed
Incyte Corporation
Phase 3
899
Busan, Daegu, Goyang-si, Incheon, Jeonju, Jinju, Seoul, Yangsan
2021-05-11
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals
Phase 3
430
Jinju, Busan, Daegu, Gyeonggi-do, Incheon, Jeonju, Seoul, Ulsan
2021-04-09
Recruiting
AstraZeneca
Phase 1
304
Cheongju-si, Goyang-si, Jinju, Seoul
2021-03-09
Active, closed
AstraZeneca
Phase 2
31
Cheongju-si, Jinju, Seoul
2021-02-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Goyang-si, Seongnam-si, Suwon, Jinju, Cheongju-si, Daegu, Seoul
2020-07-06
Active, closed
Eli Lilly and Company
Phase 3
261
Goyang-si, Seongnam-si, Incheon, Seoul, Jinju, Dongjak-gu, Daejeon
2020-02-17
Active, closed
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NCT04626882Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis
Chonnam National University Hospital
Not applicable
994
Bucheon-si, Changwon, Daegu, Gangneung, Gwangju, Jeonju, Jinju, Seoul
2019-12-30
Active, closed
AstraZeneca
Phase 3
730
Changwon-si, Cheongju-si, Daegu, Goyang-si, Jinju, Seongnam-si, Seoul, Suwon
2018-09-27
Active, closed
AstraZeneca
Phase 3
987
Changwon, Cheongju-si, Daegu, Incheon, Jinju, Seongnam-si, Seoul
2017-03-27
Active, closed
AstraZeneca
Phase 3
669
Changwon-si, Cheongju-si, Daegu, Incheon, Jinju, Seoul, Suwon
2017-01-02
Active, closed
AstraZeneca
Phase 3
1,118
Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Incheon, Jinju
2015-07-21
Active, closed
Eli Lilly and Company
Phase 3
545
Cheongju-si, Seongnam, Suwon, Jinju, Seoul, Ulsan
2015-05-06
Rows per page Showing 1–55 of 55
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/jinju

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,409 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 55 of those studies with a site in Jinju.

How many clinical trials are recruiting in Jinju?

26 of the 55 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 29 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jinju), 55 studies
PhaseStudiesRecruitingShare
Phase 3311056.4%
Not applicable6410.9%
Phase 26410.9%
Observational539.1%
Phase 1427.3%
Phase 1/2111.8%
Phase 2/3111.8%
Phase 4111.8%

Most active sponsors

Lead sponsors with the most studies (Jinju)
Lead sponsorStudiesRecruiting
AstraZeneca133
BioNTech SE43
Novartis Pharmaceuticals41
Taiho Oncology, Inc.43
AbbVie32
Chonnam National University Hospital32
Eli Lilly and Company31
Samsung Medical Center31
Amgen20
BeOne Medicines21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.